26803-UNIMED Adjara LTD - Batumi Referral Hospital
Welcome,         Profile    Billing    Logout  
 0 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Piconi, Stefania
AMMURAVID, NCT04832880 / 2020-001854-23: Factorial Randomized Trial of Rendesivir and Baricitinib Plus Dexamethasone for COVID-19 (the Trial)

Not yet recruiting
3
4000
Europe
Baricitinib Oral Tablet [Olumiant], Olumiant, Remdesivir, Veklury, Dexamethasone
ASST Fatebenefratelli Sacco, AIFA
Covid19
03/22
12/22
NCT06087640: A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age

Active, not recruiting
3
35800
Europe, RoW
aQIV or aTIV, Fluad Tetra/Quadrivalent or Fluad, QIV or TIV
Seqirus
Influenza, Human
11/26
12/26
FOSFOREAL LIFE, NCT06814899: Use of Fosfomycin in the Treatment of Bacterial Infections

Recruiting
N/A
300
Europe
Fosfomycin
Azienda Ospedaliera di Lecco
Analyze the Medical Records of Patients Admitted At ASST Lecco from 01/04/2020 to 31/12/2023 Treated with Fosfomycin IV
12/24
01/25
3-TEICO, NCT06426212: Use of Teicoplanin on a Three-weekly Administration in the Infectious Diseases Unit

Recruiting
N/A
40
Europe
Use of teicoplanin three times a week
Azienda Ospedaliera di Lecco
Comparison of Teicoplanin Used Three Times a Week in DSIs vs NDISs
05/24
06/24
Arveladze, Shalva
NCT06087640: A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age

Active, not recruiting
3
35800
Europe, RoW
aQIV or aTIV, Fluad Tetra/Quadrivalent or Fluad, QIV or TIV
Seqirus
Influenza, Human
11/26
12/26
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Piconi, Stefania
AMMURAVID, NCT04832880 / 2020-001854-23: Factorial Randomized Trial of Rendesivir and Baricitinib Plus Dexamethasone for COVID-19 (the Trial)

Not yet recruiting
3
4000
Europe
Baricitinib Oral Tablet [Olumiant], Olumiant, Remdesivir, Veklury, Dexamethasone
ASST Fatebenefratelli Sacco, AIFA
Covid19
03/22
12/22
NCT06087640: A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age

Active, not recruiting
3
35800
Europe, RoW
aQIV or aTIV, Fluad Tetra/Quadrivalent or Fluad, QIV or TIV
Seqirus
Influenza, Human
11/26
12/26
FOSFOREAL LIFE, NCT06814899: Use of Fosfomycin in the Treatment of Bacterial Infections

Recruiting
N/A
300
Europe
Fosfomycin
Azienda Ospedaliera di Lecco
Analyze the Medical Records of Patients Admitted At ASST Lecco from 01/04/2020 to 31/12/2023 Treated with Fosfomycin IV
12/24
01/25
3-TEICO, NCT06426212: Use of Teicoplanin on a Three-weekly Administration in the Infectious Diseases Unit

Recruiting
N/A
40
Europe
Use of teicoplanin three times a week
Azienda Ospedaliera di Lecco
Comparison of Teicoplanin Used Three Times a Week in DSIs vs NDISs
05/24
06/24
Arveladze, Shalva
NCT06087640: A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age

Active, not recruiting
3
35800
Europe, RoW
aQIV or aTIV, Fluad Tetra/Quadrivalent or Fluad, QIV or TIV
Seqirus
Influenza, Human
11/26
12/26

Download Options